P. Jeffrey Conn,Craig W. Lindsley,Charles David Weaver,Alice L. Rodriguez,Colleen M. Niswender,Carrie K. Jones,Richard Williams
申请号：
US13269933
公开号：
US20120028955A1
申请日:
2011.10.10
申请国别(地区):
US
年份:
2012
代理人:
摘要：
In one aspect, the invention relates to bicyclic mGluR5 positive allosteric modulators, for example 6-(phenylethynyl)-3,4-dihydroisoquinolin-1(2H)-one, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5) synthetic methods for making the compounds pharmaceutical compositions comprising the compounds and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
